AGP Executive Report
Last update: 9 hours agoMedical Cannabis Oversight: Puerto Rico’s Senate Health Committee says on-site inspections of medical cannabis establishments will happen this week, starting Tuesday at Cannalytics Bioscience Labs, then visiting Novacann Labs Corp. and Green Health Puerto Rico to check transparency, compliance, and impacts on patients’ health and quality of life. Dementia Watch: A new study in JAMA Neurology finds dementia prevalence rose sharply over two decades in several Latin American and Caribbean sites, including Puerto Rico—highlighting a growing need for prevention, care, and planning as populations age. Child Mental Health & Gut Health: A University of Puerto Rico School of Medicine-linked report claims glyphosate exposure may raise risks of anxiety, ADHD, and depression in children by disrupting the gut-brain axis and gut microbiota. Workforce & Training: Ponce Health Sciences University’s BVI campus student Lucianne Rivera earned second place in a Quality Improvement category at the San Lucas Summer Research Programme in Puerto Rico, reflecting growing local clinical research training. Health Policy Context: Separate coverage notes long-acting buprenorphine injections are increasing in use (with New Jersey still under 5%), underscoring ongoing gaps in opioid treatment access and adherence.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.